Kathreena M. Kurian

5.6k total citations
101 papers, 2.2k citations indexed

About

Kathreena M. Kurian is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Kathreena M. Kurian has authored 101 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 43 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Kathreena M. Kurian's work include Glioma Diagnosis and Treatment (47 papers), Meningioma and schwannoma management (12 papers) and Cancer Genomics and Diagnostics (10 papers). Kathreena M. Kurian is often cited by papers focused on Glioma Diagnosis and Treatment (47 papers), Meningioma and schwannoma management (12 papers) and Cancer Genomics and Diagnostics (10 papers). Kathreena M. Kurian collaborates with scholars based in United Kingdom, United States and Germany. Kathreena M. Kurian's co-authors include Hayley Ellis, A. Al‐Nafussi, Stephen P. Lowis, Claire Faulkner, Harry R. Haynes, Thomas Mathew, Ruth‐Mary deSouza, Mark Greenslade, Sarah Jefferies and Christopher Wragg and has published in prestigious journals such as The Lancet, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

Kathreena M. Kurian

97 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathreena M. Kurian United Kingdom 27 1.0k 820 426 409 286 101 2.2k
Barbara Klink Germany 25 1.0k 1.0× 855 1.0× 530 1.2× 775 1.9× 180 0.6× 73 2.5k
Adam Resnick United States 30 1.8k 1.8× 1.1k 1.3× 447 1.0× 326 0.8× 574 2.0× 112 3.3k
Wenbin Ma China 30 679 0.7× 1.0k 1.3× 420 1.0× 375 0.9× 224 0.8× 175 2.7k
Stephen Yip Canada 30 1.0k 1.0× 567 0.7× 565 1.3× 655 1.6× 156 0.5× 150 2.8k
Deric M. Park United States 26 861 0.8× 568 0.7× 543 1.3× 490 1.2× 192 0.7× 54 2.1k
Juxiang Chen China 29 1.5k 1.5× 457 0.6× 496 1.2× 864 2.1× 193 0.7× 76 2.6k
Naoki Shinojima Japan 26 1.3k 1.2× 1.3k 1.5× 682 1.6× 602 1.5× 363 1.3× 80 3.0k
Yicheng Lu China 31 1.6k 1.5× 356 0.4× 399 0.9× 805 2.0× 263 0.9× 134 2.7k
Adam L. Cohen United States 25 1.2k 1.2× 952 1.2× 452 1.1× 906 2.2× 137 0.5× 82 2.7k
Qianghu Wang China 22 1.1k 1.1× 407 0.5× 406 1.0× 649 1.6× 111 0.4× 59 2.1k

Countries citing papers authored by Kathreena M. Kurian

Since Specialization
Citations

This map shows the geographic impact of Kathreena M. Kurian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathreena M. Kurian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathreena M. Kurian more than expected).

Fields of papers citing papers by Kathreena M. Kurian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathreena M. Kurian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathreena M. Kurian. The network helps show where Kathreena M. Kurian may publish in the future.

Co-authorship network of co-authors of Kathreena M. Kurian

This figure shows the co-authorship network connecting the top 25 collaborators of Kathreena M. Kurian. A scholar is included among the top collaborators of Kathreena M. Kurian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathreena M. Kurian. Kathreena M. Kurian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daly, Richard, et al.. (2024). Efficacy of PD-1/PD-L1 immunotherapy on brain metastatic non-small-cell lung cancer and treatment-related adverse events: A systematic review. Critical Reviews in Oncology/Hematology. 196. 104288–104288. 3 indexed citations
2.
Adams, Claire, Emanuela Ercolano, David A. Hilton, et al.. (2024). Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours. Oncogene. 43(41). 3049–3061. 1 indexed citations
3.
Robinson, Jamie, Richard M. Martin, Mio Ozawa, et al.. (2024). Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case–control studies using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 14(2). e072026–e072026. 1 indexed citations
4.
Zhao, Huiling, et al.. (2024). Brain multi-omic Mendelian randomisation to identify novel drug targets for gliomagenesis. Human Molecular Genetics. 34(2). 178–192. 1 indexed citations
5.
Howell, Amy, Caroline L. Relton, Richard M. Martin, Jie Zheng, & Kathreena M. Kurian. (2023). Role of DNA methylation in the relationship between glioma risk factors and glioma incidence: a two-step Mendelian randomization study. Scientific Reports. 13(1). 6590–6590. 5 indexed citations
6.
7.
Hilton, David A., David B. Parkinson, Emanuela Ercolano, et al.. (2021). Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma. Cancer Research. 82(2). 235–247. 21 indexed citations
8.
Brandner, Sebastian, Alexandra McAleenan, Hayley E Jones, et al.. (2021). Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review. Neuropathology and Applied Neurobiology. 48(4). e12790–e12790. 18 indexed citations
9.
Hilton, David A., Sylwia Ammoun, Daniele Baiz, et al.. (2021). Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas. International Journal of Molecular Sciences. 22(2). 560–560. 14 indexed citations
10.
Brandner, Sebastian, Alexandra McAleenan, Claire Kelly, et al.. (2021). MGMTpromoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro-Oncology. 23(9). 1457–1469. 39 indexed citations
11.
Carruthers, Ross, Shafiq U. Ahmed, Shaliny Ramachandran, et al.. (2018). Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells. Cancer Research. 78(17). 5060–5071. 106 indexed citations
12.
Haynes, Harry R., Kelly Hares, Juliana Redondo, et al.. (2018). Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays. Journal of Clinical Pathology. 71(8). 695–701. 13 indexed citations
13.
Brennan, Paul M., Kathreena M. Kurian, William Hollingworth, et al.. (2018). Symptoms in primary care with time to diagnosis of brain tumours. Family Practice. 35(5). 551–558. 26 indexed citations
14.
Kemp, Kevin, et al.. (2016). Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia. Acta Neuropathologica Communications. 4(1). 53–53. 36 indexed citations
15.
Faulkner, Claire, et al.. (2015). Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas. Frontiers in Oncology. 5. 54–54. 74 indexed citations
16.
deSouza, Ruth‐Mary, et al.. (2014). Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies. Frontiers in Oncology. 4. 176–176. 59 indexed citations
17.
18.
Kurian, Kathreena M., et al.. (2003). Retention of corneal epithelial cells following Goldmann tonometry. British Journal of Ophthalmology. 87(5). 1 indexed citations
19.
Young, Irene, Kathreena M. Kurian, I. Kunkler, et al.. (2000). A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer. British Journal of Cancer. 82(7). 1247–1248. 4 indexed citations
20.
Marson, Lorna, Kathreena M. Kurian, William R. Miller, & J. Michael Dixon. (1999). Reproducibility of microvessel counts in breast cancer specimens. British Journal of Cancer. 81(6). 1088–1093. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Klink Breakdown of academic impact, for papers by Adam Resnick Breakdown of academic impact, for papers by Wenbin Ma Breakdown of academic impact, for papers by Stephen Yip Breakdown of academic impact, for papers by Deric M. Park Breakdown of academic impact, for papers by Juxiang Chen Breakdown of academic impact, for papers by Naoki Shinojima Breakdown of academic impact, for papers by Yicheng Lu Breakdown of academic impact, for papers by Adam L. Cohen Breakdown of academic impact, for papers by Qianghu Wang
Rankless by CCL
2026